Hered Cancer Clin Pract. 2004 Feb 15;2(1):5-10.

The prevention of hereditary breast and ovarian cancer: a personal view.

Source

Centre for Research on Women's Health, University of Toronto, Toronto, Ontario, Canada. steven.narod@swchsc.on.ca.

Abstract

ABSTRACT: Options for the prevention of hereditary breast and ovarian cancer include screening, preventive surgery and chemoprevention. Screening studies with magnetic resonance imaging of the breast are promising but the technology is not widespread and MRI is unlikely to be available as a screening tool in the near future. Prophylactic oophorectomy and mastectomy are effective preventive measures and are gaining in acceptance by patients and physicians. Preventive mastectomy is effective against both primary and contralateral breast cancer. Oophorectomy prevents ovarian cancer, and if done prior to menopause, will prevent breast cancer as well. Tamoxifen has been shown to prevent contralateral breast cancers in BRCA1 and BRCA2 carriers but is not widely accepted as a means of primary prevention. Oral contraceptives and tubal ligation will reduce the risk of hereditary ovarian cancer and should be considered in women who wish to retain ovarian function.

PMID:: 20233484; [PubMed - in process]
PMCID:: PMC2839994

Free PMC Article

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. [Oncologist. 1996]
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS. Oncologist. 1996; 1(5):326-330.
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. [Int J Cancer. 2008]
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, et al. Int J Cancer. 2008 May 1; 122(9):2017-22.
Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. [JAMA. 2000]
Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.
Schrag D, Kuntz KM, Garber JE, Weeks JC. JAMA. 2000 Feb 2; 283(5):617-24.
Review Prophylactic surgery in hereditary breast/ovarian cancer syndrome. [Oncology (Williston Park). 2003]
Review Prophylactic surgery in hereditary breast/ovarian cancer syndrome.
Levine DA, Gemignani ML. Oncology (Williston Park). 2003 Jul; 17(7):932-41; discussion 946-8, 950-2.
Review Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations. [Womens Health (Lond Engl). 2009]
Review Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations.
Metcalfe KA. Womens Health (Lond Engl). 2009 Jan; 5(1):63-8.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

The prevention of hereditary breast and ovarian cancer: a personal view.
The prevention of hereditary breast and ovarian cancer: a personal view.
Hered Cancer Clin Pract. 2004 Feb 15 ;2(1):5-10.

PubMed
BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rear...
BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan.
Leuk Lymphoma. 2010 Apr ;51(4):650-5.

PubMed
Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailabi...
Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice.
J Agric Food Chem. 2010 Apr 14 ;58(7):4523-8.

PubMed
Interleukin 10 receptor alpha subunit (IL-10RA) gene polymorphism and IL-10 seru...
Interleukin 10 receptor alpha subunit (IL-10RA) gene polymorphism and IL-10 serum levels in Egyptian atopic patients.
J Investig Allergol Clin Immunol. 2010 ;20(1):20-6.

PubMed
Projections of the incidence of non-Hodgkin's lymphoma related to acquired immun...
Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome.
J Natl Cancer Inst. 1991 May 15 ;83(10):695-701.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

The prevention of hereditary breast and ovarian cancer: a personal view.

Source

Abstract

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information